Similar articles

• Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.

  Isozumi R, Yoshimine H, Morozumi M, Ubukata K, Ariyoshi K. Isozumi R, et al. Respirology. 2009 Nov;14(8):1206-8. doi: 10.1111/j.1440-1843.2009.01619.x. Epub 2009 Sep 1. Respirology. 2009. PMID: 19732389
• Chlamydia pneumoniae and Mycoplasma pneumoniae.

  Blasi F, Tarsia P, Aliberti S, Cosentini R, Allegra L. Blasi F, et al. Semin Respir Crit Care Med. 2005 Dec;26(6):617-24. doi: 10.1055/s-2005-925525. Semin Respir Crit Care Med. 2005. PMID: 16388430 Review.
• [Asthma and Mycoplasma pneumoniae].

  Blanchard E, Raherison C. Blanchard E, et al. Rev Mal Respir. 2010 Oct;27(8):890-7. doi: 10.1016/j.rmr.2010.04.002. Epub 2010 May 20. Rev Mal Respir. 2010. PMID: 20965403 Review. French.
• Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.

  Miyashita N, Oka M; Atypical Pathogen Study Group; Kawai Y, Yamaguchi T, Ouchi K. Miyashita N, et al. Int J Antimicrob Agents. 2010 Oct;36(4):384-5. doi: 10.1016/j.ijantimicag.2010.06.009. Epub 2010 Jul 31. Int J Antimicrob Agents. 2010. PMID: 20674283 No abstract available.
• Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.

  Principi N, Esposito S, Blasi F, Allegra L; Mowgli study group. Principi N, et al. Clin Infect Dis. 2001 May 1;32(9):1281-9. doi: 10.1086/319981. Epub 2001 Apr 10. Clin Infect Dis. 2001. PMID: 11303262 Clinical Trial.